Russell Investments Group’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Buy
8,167
+5,497
+206% +$161K ﹤0.01% 3021
2026
Q1
$65.9K Sell
2,670
-47,024
-95% -$822K ﹤0.01% 3219
2025
Q4
$840K Sell
49,694
-5,171
-9% -$91K ﹤0.01% 2303
2025
Q3
$1.19M Buy
54,865
+36,753
+203% +$610K ﹤0.01% 2134
2025
Q2
$258K Buy
+18,112
New +$286K ﹤0.01% 2575
2021
Q3
– Sell
-36,079
Closed -$222K – 3084
2021
Q2
$222K Hold
36,079
– – ﹤0.01% 2873
2021
Q1
$264K Hold
36,079
– – ﹤0.01% 2756
2020
Q4
$293K Sell
36,079
-45,626
-56% -$352K ﹤0.01% 2636
2020
Q3
$645K Buy
+81,705
New +$558K ﹤0.01% 2277

Other funds holding ETON

Russell Investments Group's ETON Position: Q2 2026 in Review

Russell Investments Group increased its Eton Pharmaceutcials (ETON) stake by 206% in Q2 2026, buying an estimated $161K and bringing the position to 8,167 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #3021.

Russell Investments Group first reported a position in ETON in Q3 2020 and has held it in 9 quarters since. The position peaked at $1.19M in Q3 2025. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Russell Investments Group held 8,167 shares of Eton Pharmaceutcials worth $296K as of Q2 2026.
  • Russell Investments Group bought 5,497 Eton Pharmaceutcials shares in Q2 2026, an estimated $161K.
  • Eton Pharmaceutcials made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3021 holding.
  • Russell Investments Group first reported a position in Eton Pharmaceutcials in Q3 2020 and has held it in 9 quarters since.
  • Russell Investments Group's Eton Pharmaceutcials position peaked at $1.19M in Q3 2025.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.